The Global Market for Biopreservation Equipment and Media is Projected to Reach US$3.9 Billion by 2020

Mushrooming Biorepository Facilities for R&D & Development of Regenerative & Personalized Medicines Drive the Biopreservation Market, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Biopreservation market. The global market for Biopreservation Equipment and Media is projected to reach US$3.9 billion by 2020, driven by mushrooming biorepository facilities for R&D and development of regenerative and personalized medicines.

In the light of the growing prevalence of chronic diseases, such as cancer, cardiovascular diseases, diabetes, neurovascular diseases, and acute respiratory diseases, Biopreservation is being acknowledged as strategically important activity for every nation. The growing need for more effective modalities for preventing, diagnosing, and treating such life-threatening diseases is driving the need for demographic and age-based biopreservation facilities for academic and clinical research. Large scale academic institutions, state bodies, healthcare establishments, and pharmaceutical and biotechnology companies are funding biorepositories and biobanks that provide characterized Human Biological Samples (HBS) to support both pre-clinical and clinical research. Human biospecimens are being used in a growing number of clinical studies for biomarker exploration, as well as a means of insuring against costly drug trial failures.

Advancements in the field of companion diagnostics and personalized medicines, comprising drugs designed to match the genetic characteristic of each individual, will continue to act as a growth catalyst for biopreservation. Biopreservation Media is being increasingly used by life sciences companies for developing cell or tissue based therapies. A key challenge confronting the market is the need to develop methods to extend the functional lifespan of vascularized composite tissues and organs, and engineered tissues. Preservation media solutions that can prolong the viability of organs and tissues post harvest have huge implications in the field of transplantation and reconstructive medicine, particularly in bridging the gap between the demand and supply of vital human organs.

Biobanks are increasingly adopting automated systems and software tools in order to improve storage, management, and retrieval of HBS without sacrificing sample integrity and sustainability. Micro Electromechanical Systems (MEMS) and Radio Frequency Identification (RFID) tags are emerging as cost-effective and error-free technologies for labeling biosamples with several long-term benefits when compared to traditional methods. Efficient utilization of storage space down to each refrigerator or freezer unit is critical given that the growing volume and diversity of HBS that need to be preserved. Amid growing calls for reducing operating cost of biopreservation facilities, growing in popularity are dry storage vessels and room temperature preservation methods, such as Dried Blood Spots (DBS).  

As stated by the new market research report on Biopreservation, the United States represents the largest market worldwide, supported by the large number of biorepositories operating in the country, and the adoption of advanced biopreservation technologies. Asia-Pacific ranks as the fastest growing market with a CAGR of 17.2% over the analysis period, driven by growing consumer interest in stem cell banking. Biopreservation Media represents the larger as well as the faster growing product market, while R&D constitutes the biggest and one of the fastest growing application segments for biopreservation equipment and media.

Major players profiled in the report include Atlanta Biologicals Inc., Biocision LLC, Biogenics Inc., Biolife Solutions Inc., Cell & Tissue Systems Inc., Cesca Therapeutics Inc., Core Dynamics, Ltd.,  Custom Biogenic Systems Inc., Essential Pharmaceuticals LLC, Lifeline Scientific Inc., Panasonic Biomedical Sales Europe B.V., Preservation Solution, Inc., Princeton Cryotech Inc., Sigma-Aldrich Corporation, So-Low Environmental Equipment Co. Inc., Taylor-Wharton Cryogenics LLC, Thermo Fisher Scientific Inc., VWR International LLC, and Wak-Chemie Medical Gmbh

The research report titled “Biopreservation: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies.  The report provides market estimates and projections for all major geographic markets, such as the US, Canada, Japan, Europe (France, Germany,  Italy,  UK, Spain, Russia, The Netherlands, and Rest of Europe), Asia-Pacific (China, India, and Rest of Asia-Pacific), Latin America (Brazil, and Rest of Latin America), and Rest of World. The global market is further analyzed by product segments – Equipment and Media, and by Applications- R&D, Therapeutic, and Others. Market sizes and forecasts are also provided for Biospecimen Types: Organs, Stem Cells, Tissues, and Others. 

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.